Martin Guimond

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Corrigendum: Role of endothelial cells in graft-versus-host disease.

Corrigendum: Role of endothelial cells in graft-versus-host disease.

Journal: Frontiers in immunology

Published: December 15, 2022

Role of endothelial cells in graft-versus-host disease.

Role of endothelial cells in graft-versus-host disease.

Journal: Frontiers in immunology

Published: August 31, 2022

Modulating endothelial cells with EGFL7 to diminish aGVHD after allogeneic bone marrow transplantation in mice.

Modulating endothelial cells with EGFL7 to diminish aGVHD after allogeneic bone marrow transplantation in mice.

Journal: Blood advances

Published: June 10, 2021

Correction: Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients.

Correction: Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients.

Journal: Blood cancer journal

Published: November 05, 2020

Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions.

Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions.

Journal: Blood cancer discovery

Published: September 25, 2020

Studying Peripheral T Cell Homeostasis in Mice: A Concise Technical Review.

Studying Peripheral T Cell Homeostasis in Mice: A Concise Technical Review.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: January 15, 2020

MicroRNAs in graft-versus-host disease: a review of the latest data.

MicroRNAs in graft-versus-host disease: a review of the latest data.

Journal: Bone marrow transplantation

Published: May 04, 2019

IL-7 Is the Limiting Homeostatic Factor that Constrains Homeostatic Proliferation of CD8+ T Cells after Allogeneic Stem Cell Transplantation and Graft-versus-Host Disease.

IL-7 Is the Limiting Homeostatic Factor that Constrains Homeostatic Proliferation of CD8+ T Cells after Allogeneic Stem Cell Transplantation and Graft-versus-Host Disease.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: October 05, 2018

Double-Negative T Cell Levels Correlate with Chronic Graft-versus-Host Disease Severity.

Double-Negative T Cell Levels Correlate with Chronic Graft-versus-Host Disease Severity.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: June 22, 2018

Restoring T Cell Homeostasis After Allogeneic Stem Cell Transplantation; Principal Limitations and Future Challenges.

Restoring T Cell Homeostasis After Allogeneic Stem Cell Transplantation; Principal Limitations and Future Challenges.

Journal: Frontiers in immunology

Published: March 02, 2018

Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients.

Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients.

Journal: Blood cancer journal

Published: January 13, 2017

Homeostatic cytokines in immune reconstitution and graft-versus-host disease.

Homeostatic cytokines in immune reconstitution and graft-versus-host disease.

Journal: Cytokine

Published: October 31, 2015

Showing 1-12 of 18

Last Updated: 09/26/2026